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INTRODUCTION
A number of newborns and infants are inevitably prescribed 
with anesthesia for a much needed treatment outcome. Ac-
cordingly, concerns are raised about the developmental liabil-
ity of exposed individuals to the long term effects of neonatal 
anesthesia with a much greater need to study its alleged im-
pact in humans (Sun, 2010). The early postnatal age is thought 
to display the highest vulnerability to anesthetics, especially 
in an immature and rapidly developing brain. In humans, this 
so-called brain growth spurt period begins at mid-pregnancy 
and continues well until 2 years postnatal age (Dobbing and 
Sands, 1973). Some clinical studies offered hints of increased 
risk of neurodevelopmental disturbances in children exposed 
to multiple, but not single, administration of anesthesia during 
the earliest ages (Wilder et al., 2009; Yan et al., 2014). How-
ever, clinical reports are limited and inconclusive.
Preclinical studies provided a clearer outcome of neona-
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Propofol is an anesthetic agent that gained wide use because of its fast induction of anesthesia and rapid recovery post-anes-
thesia. However, previous studies have reported immediate neurodegeneration and long-term impairment in spatial learning 
and memory from repeated neonatal propofol administration in animals. Yet, none of those studies has explored the sex-specific 
long-term physical changes and behavioral alterations such as social (sociability and social preference), emotional (anxiety), and 
other cognitive functions (spatial working, recognition, and avoidance memory) after neonatal propofol treatment. Seven-day-old 
Wistar-Kyoto (WKY) rats underwent repeated daily intraperitoneal injections of propofol or normal saline for 7 days. Starting fourth 
week of age and onwards, rats were subjected to behavior tests including open-field, elevated-plus-maze, Y-maze, 3-chamber 
social interaction, novel-object-recognition, passive-avoidance, and rotarod. Rats were sacrificed at 9 weeks and hippocampal 
protein expressions were analyzed by Western blot. Results revealed long-term body weight gain alterations in the growing rats 
and sex-specific impairments in spatial (female) and recognition (male) learning and memory paradigms. A markedly decreased 
expression of hippocampal NMDA receptor GluN1 subunit in female- and increased expression of AMPA GluR1 subunit protein 
expression in male rats were also found. Other aspects of behaviors such as locomotor activity and coordination, anxiety, so-
ciability, social preference and avoidance learning and memory were not generally affected. These results suggest that neonatal 
repeated propofol administration disrupts normal growth and some aspects of neurodevelopment in rats in a sex-specific manner.
Key Words: Propofol, Anesthesia, Neurodevelopment, Sex-difference, Weight gain, Learning and memory 
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tal anesthesia, especially in studying the immediate neuro-
chemical and long-term behavioral or neurocognitive effects 
in animal models, as ethical concerns limit the application of 
some studies in humans. Using rat models, anesthesia can 
be induced during the brain growth spurt period, which had 
been previously determined to be during 2 weeks of age (Dob-
bing and Sands, 1973). Indeed, exposure of neonatal rodent 
models to a variety of clinical anesthetics being studied (e.g. 
ketamine, nitrous oxide, isoflurane, sevoflurane, and propofol) 
induced neuroapoptotic events with long term behavioral, so-
cial and neurocognitive consequences (Jevtovic-Todorovic et 
al., 2003; Yon et al., 2005; Cattano et al., 2008; Satomoto et 
al., 2009; Milanovic et al., 2010; Cui et al., 2011; Karen et al., 
2013; Yu et al., 2013). In particular, our group has given inter-
est in propofol which showed a rapidly increasing evidence 
of its deleterious effects in preclinical studies (Cattano et al., 
2008; Milanovic et al., 2010; Cui et al., 2011; Karen et al., 
2013; Yu et al., 2013).
The small molecule propofol (2, 6-diisopropylphenol) is an 
anesthetic or sedative that gained wide use in pediatrics be-
cause of its expedient pharmacokinetics for the fast onset of 
anesthesia and rapid recovery (Mallory et al., 2011). GABA-A 
receptors are thought to be the target of propofol (Feng et al., 
2007) with observed lesser impact on excitatory amino acid 
receptors. Propofol is being prescribed to younger children, 
yet little is known about its long term outcome. Animal models 
of neonatal propofol induction have shown the appearance of 
neuroapoptosis (Cattano et al., 2008; Cui et al., 2011; Karen 
et al., 2013; Milanovic et al., 2010; Yu et al., 2013), impaired 
brain circuitry (Briner et al., 2011), and long term effects on 
cortical- and hippocampal-related learning and memory per-
formance (Feng et al., 2007; Gao et al., 2014; Yu et al., 2013). 
However, none of these studies has attempted to evaluate 
whether propofol-induced impairments have sex-specific dif-
ferences. Furthermore, physical growth, locomotor activity, 
anxiety, social behaviors, and other aspects of learning and 
memory are also substantially important areas of evaluation to 
elucidate the effects of propofol treatment in neonates, which 
we thus sought in the present study. 
The main objective of this study is to explore the long-term 
physical, emotional, social and cognitive effects of repeated 
neonatal propofol exposure in rats. We also intended to assess 
if these long-term effects have sex-specificity. The outcome of 
this study will support and add more preclinical evidence to 
open new insights on the long-term effects of neonatal propo-
fol administration that may possibly occur in humans.
MATERIALS AND METHODS
Animals and treatment conditions
All procedures and animal handling were in agreement 
with the approved Animal Care and Use Guidelines of Sah-
myook University, Korea, and Konkuk University, Korea; and 
were carried out in compliance to the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals 
(NIH Publications No. 8023, revised 1978). All subjects were 
maintained on a 12:12-h circadian cycle (lights on at 07:00 
and off at 19:00), in a constant temperature (22 ± 2oC) and 
humidity (55 ± 5%). Forty-seven Wistar Kyoto rats (WKY) 
from 6 dams were used in this study. In each litter at P7, pups 
were divided into 4 groups by treatment and sex and were 
almost equally distributed per group. Each pup was marked 
and numbered with indelible ink according to the group it be-
longs. After weighing (averaging from 12-16 g), all pups were 
administered with either normal saline or propofol (10 mg/ml, 
Claris Lifesciences limited, India) through intraperitoneal in-
jection for 7 days, in three divided doses per day with 90 min 
interval at 40, 20, 20 mg/kg dosages, respectively. Dams were 
removed from the cages during the administration period, then 
returned to each cage after the pups regained full conscious-
ness. During administration period, pups were kept warm at 
body temperature by placing heating pad under and heating 
lamps above the cages. Previous experiments of higher dos-
ages and longer series of injections of propofol confirmed that 
animals do not show respiratory, metabolic, circulatory, or gly-
cemic alterations (Briner et al., 2011; Yu et al., 2013; Gao et 
al., 2014). Pups were closely monitored during the sedated 
state observing their appearance and respiration. Weights 
were continuously monitored until weaned at P24. Weaned 
rats were housed by group (3-4 per cage) and sex, and were 
given food and water ad libitum. All efforts were done to mini-
mize the number of animals used in the experiments and to 
minimize their suffering. Animals were assigned according to 
sex and treatment condition in the following groups and num-
ber of animals: Control (male, n=8; female, n=13) and propo-
fol-exposed (male, n=10; female, n=16).
Behavior experiments
All behavior experiments were conducted from 4 to 8 weeks 
of age and sufficient amount of rest intervals were given to 
the subjects in each experiment (Fig.1). Experimental proce-
dures were carried out in designated testing rooms and ani-
mals were habituated in the area for an hour before the actual 
experiments began. Tests were conducted in the active phase 
(dark cycle) of the animals as necessary or in the light phase 
otherwise. Experiments were sequenced according to the 
Control=7 complete doses of saline
Propofol=7 complete doses of propofol
Saline/Propofol administration
Week 1 Week 2 Week 3 Week 4 Week 5 Week 9Week 6 Week 7 Week 8
Postnatal
days>
8 9 10 11 12 13
7 14 21 28 6335 42 49 560
30 32
Weaning
Y maze
EPM
Open field
Social
interaction
test
Novel object
recognition
test
Brain
extraction
Accelerating
rotarod
test
Passive
avoidance
test
Fig. 1. Propofol administration and behavioral experiment scheme.
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complexity and averseness of the test with the most aversive 
at the end. For most of the tests, an overhead video record-
ing apparatus (CCD camera) connected to a computer was 
installed and behaviors were automatically tracked by EthoVi-
sion software (EthoVision 3.1, Noldus Information Technology, 
the Netherlands). Floors of testing equipment were thoroughly 
cleaned with 70% ethanol at the end of each trial.
Open field test
At P28, rats were allowed to explore the open field area for 
15 minutes to assess the general locomotor activity of rats. 
Five black boxes (42×42×42[height] cm) made of polyvinyl-
chloride (PVC) were available to accommodate 5 animals si-
multaneously. After introducing each animal to the center area 
as the test commenced, the distance moved and movement 
duration were automatically tracked by EthoVision software. 
Movement to the center area (20×20 cm2) was also assessed 
as a measure of anxiety behavior (Prut and Belzung, 2003).
Elevated plus maze (EPM) test
At P30, rats were tested in the EPM apparatus at 60 cm 
elevation. The maze was made of PVC forming a plus shape. 
Two open arms (50×10 cm) and 2 close arms (50×10×30 
[height] cm) were interconnected forming the neutral area 
(10×10 cm) in the center. Subjects of each group were alter-
nately tested in the maze for 8 minutes, initially placing each 
subject in the neutral area facing an open arm. Automatic re-
cording of movement and placement was done through Etho-
Vision software. The parameters of anxiety measured in this 
test, frequency of entry and time spent in the open arms, were 
analyzed by calculating their percentages from the total arm 
entries and time spent, respectively (Pellow et al., 1985).
Y maze test
Two days after EPM test, rats were subjected to the Y 
maze apparatus to assess the spatial learning and memory 
of propofol-exposed animals (Maurice et al., 1999). An equally 
angled Y maze made of PVC materials was used, measuring 
50×10×20 cm each arm. Each rat, alternately tested in each 
group, was first introduced in one end of the Y maze facing 
the central intersection and allowed to explore for 8 minutes. 
An arm entry was counted when the four paws and tail of the 
rat enter an arm zone. A complete alternation was recorded 
when the rat enters different arms in three successive entries. 
Finally, total entries and spontaneous alternations of entries 
(total alternations/[total entries-2]×100) in the Y maze were 
calculated (Sarter et al., 1988).
Three-chamber sociability and social novelty preference 
tests
Sociability and social novelty preference tests are meth-
ods to evaluate the social ability of a subject rat to explore a 
stranger rat in a wire cage over the empty cage (phase 1), and 
preference to novel stranger rat over an already familiar one 
(phase 2), respectively. This method was first established by 
Moy and colleagues (Moy et al., 2004) and was slightly modi-
fied in our laboratory (Kim et al., 2011) to accommodate the 
rat subjects and the EthoVision software as the technology 
used to measure the parameters of the experiment. Here, we 
summarized the method in brief (please see (Kim et al., 2011), 
for details).
Sociability and social novelty preference tests were con-
ducted from P35-38 age of rats and in each day of experi-
ment, each group is evenly represented. The test was per-
formed in a three-chamber rectangular cage (23×40×22 cm 
in each compartment) and two 10-cm2 openings provided 
access to the three chambers. The whole experiment was di-
vided into two phases. Before phase 1, subject rats were ha-
bituated in the 3-chamber apparatus for 5 minutes. As phase 
one commenced, two wire cages were introduced containing 
either an unfamiliar rat inside or nothing (empty) in both side 
chambers with an alternation to which side of the chambers 
the stranger rat was placed in each trial. The subject rat was 
then allowed to explore each chamber and wire cages for 10 
minutes. Phase two commenced immediately after sociabil-
ity test wherein another novel stranger rat was placed in the 
previously empty cage to compare the preference for novelty. 
Another 10 minutes was allotted for the subject rat to explore 
the chambers in this test. Time spent in each chamber was 
measured automatically through EthoVision software. Sniffing 
duration towards the wire cages was also recorded through 
manual observation 2 meters from the testing apparatus.
Novel object recognition test (NORT)
The recognition aspect of learning and memory was as-
sessed in subject rats on their 42nd-45th days of age. Using 
the same apparatus for the three chamber social tests, while 
removing the two center walls that divided the chambers, 
rats were once again allowed to explore this arena during the 
novel object recognition test. The social tests primarily served 
as the habituation phase for the NORT. The NORT has three 
phases: habituation, familiarization and novel object recogni-
tion as described previously with some modifications (Bevins 
and Besheer, 2006). In every phase, each rat was placed at 
the start area near the front wall.
After 5 minutes of habituation in the empty area, each test-
ed rat was moved to an empty transport box while two identi-
cal objects (blue bottles) were placed in the testing box and 
taped on the floor for stabilization. The objects were placed in 
two opposite and equidistant locations; 50 cm from the front 
wall, 15 cm from the back wall, 10 cm from the sidewalls and 
12 cm apart. Thereafter, as the familiarization phase began, 
each subject was allowed to explore the objects for 10 min. 
Object exploration was defined when the rat’s nose was in 
close proximity (<2 cm) to the object while the vibrissae were 
moving but not when the body of the rats touched the object 
but the head was in another direction.
Three hours after the familiarization trial, subject was re-
introduced to the arena for novel object recognition test. This 
time, one object during the familiarization phase was alter-
nately replaced with a novel object (Pororo character toy). 
Object exploration time was recorded for 5 min between the 
novel and the familiar object. Novel object preference index 
was also calculated as: novel object exploration time/(novel 
object exploration time+familiar object exploration time)×100 
(%) (Wang et al., 2007). After each trial, the arena floor and 
the objects were wiped with 70% ethanol to eliminate odor 
cues for the next subject.
Passive avoidance test
At P49-50, subject rats were tested in the one-trial passive 
avoidance test as previously described (D'Agata and Caval-
laro, 2003), with slight modifications. The test involved the ex-
posure of the rat to the passive avoidance apparatus (Gemini 
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avoidance apparatus, San Diego Instruments, San Diego, CA, 
USA). The apparatus has two chambers: one lighted and one 
dark compartment separated by a switch-operated guillotine 
door. During the conditioning phase, subjects were initially put 
in the light chamber for 10 s before the door was raised to al-
low access to the dark chamber. Once the rat was in the dark 
chamber, the door was closed and shock was delivered for 2 
s (1 mA intensity) before rat was taken back to its home cage. 
Latency to enter the dark chamber up to 5 minutes maximum 
time was recorded. 24 h later, rats were tested again with the 
same procedure but no shock was given when a rat enters the 
dark chamber. Latency to enter the dark chamber was again 
recorded as an indicator of avoidance or training experience 
memory (D'Agata and Cavallaro, 2003).
Fig. 2. Mean body weight gain alteration of rats after neonatal repeated administration of propofol from (A) P7 to P24, and (B) at P56. Bars 
indicate the mean ± SEM. Control (male, n=8; female, n=13) and propofol (male, n=10; female, n=16). *p<0.05 and **p<0.01 vs control 
male, #p<0.05 vs control female.
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Rotarod test
The final behavior test done for all rats was the rotating rod 
(Rota Rod, Ugo Basile S.R.L., Italy) in accelerating speed as 
described previously with some modifications (Morgan et al., 
2008). The rats were given 2 training sessions to acclimate to 
the mechanics of the rotating corrugated drum by walking and 
balancing on it until they fall. The drums were set to rotate at 
an accelerating speed from 5 to 25 rpm during a 5-minute trial 
period. Latency to fall was recorded and the whole experiment 
was done for 3 successive days with one trial per day.
Brain dissection
A week after the last behavior experiment, about 8 to 10 
rats each group were decapitated through rodent guillotine 
for brain dissection and molecular studies. Hippocampi were 
isolated and flash frozen in the liquid nitrogen for further mo-
lecular analysis. 
Western blot analysis
Tissues were homogenized with 500 ml homogenization 
buffer (50 mM Tris-HCl [pH.7.4] 150 mM NaCl) including pro-
teinase inhibitor cocktail. Homogenized samples were centri-
fuged at 13,200 rpm for 20 min at 4oC. After centrifugation, 
supernatants were harvested and added with 2x sample buffer 
then boiled using heat block at 100oC. The collected aliquot of 
proteins were separated by 10% SDS-PAGE and transferred 
to nitrocellulose membranes. The membranes were blocked 
with 5% skim milk in TBS including 1% tween-20 for 1 h. 
Thereafter, the membranes were incubated with first antibody 
overnight at 4oC and then with peroxidase-conjugated sec-
ondary antibody (Santa Cruz, CA, USA) for 2 h at room tem-
perature. Specific bands were detected using the ECL system 
(Amersham, Buckinghamshire, UK) and exposed to LAS3000. 
Antibodies 
Antibodies against PSD95 (AB9708), GAD65/67 (AB1511), 
NMDA receptor (AB9864), Glutamate receptor 1 (AB31232), 
Glutamate receptor 2 (AB20673), NMDA receptor 2A (AB1555p), 
NMDA receptor 2B (AB1557p) were obtained from Millipore (Bil-
lerica, MA, USA) and beta-actin (A5316) from Sigma Aldrich (St. 
Louis, MO, USA). 
Statistical analysis
All data were expressed as mean ± SEM. Statistical analy-
ses were conducted using GraphPad Prism version 5.03 for 
Windows, GraphPad Software, San Diego, CA, USA. Two way 
ANOVA was used to measure effects of sex and treatment, or 
time and treatment, and interaction between each two vari-
ables, then Bonferroni post test was used as post hoc analy-
sis. Male and female data were separated according to the 
objective of this study. Unpaired t-test was also used to cal-
culate the difference between control and propofol-exposed 
groups in each sex.
RESULTS
Long-term body weight alteration of offspring following 
neonatal repeated administration of propofol
There were significant effects of neonatal repeated pro-
pofol administration on the weight profile of male and female 
offspring rats (F(3, 43)=3.838, p<0.05) (Fig. 2). An altered body 
weight gain was observed after the first day of propofol admin-
istration that differed significantly from the control during P22 
to P24 weaning and grouping period (Fig. 2A). At P56 (Fig. 
2B), propofol-treated males showed a persistent decrease in 
body weight than male controls (p<0.01) but no difference be-
tween females was found (p>0.05).
Slightly increased locomotor activity in early exploration 
of female rats and no effect in anxiety related behaviors 
following neonatal repeated administration of propofol
Neonatal repeated propofol administration did not show an 
effect on overall activity in the open field arena for the whole 
15 min duration of exploration in either the distance moved 
(F(1, 43)=0.3545, p=0.55) (Fig. 3C) or the movement duration 
(F(1, 43)=0.2391, p=0.62) (Fig. 3D) parameters. However, a 
significant increase in distance moved during the first 3 min-
utes of exploration in the open field (Fig. 3A) was observed in 
the propofol-treated female versus the control female group 
(p<0.05) but not in between male groups (p>0.05). The suc-
ceeding minutes (time bins) of exploration did not show any 
more differences in locomotor activity of groups. Anxiety-re-
lated behaviors were not also evident in propofol-treated sub-
Fig. 4. Effects of neonatal repeated propofol administration on 
anxiety-related behaviors and locomotor activity of rats in the el-
evated plus maze at P30 by (A) percentage of entry in open arms/
total arm-entries and (B) percentage of time spent in open arms/
total time spent in all arms. Bars indicate the mean ± SEM. Con-
trol (male, n=8; female, n=13) and propofol (male, n=10; female, 
n=16). No significant difference was observed.
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jects as measured by time spent in the center area of the open 
field (Fig. 3E) or the parameters assessed in the elevated plus 
maze (Fig. 4).
Impaired spontaneous alternation ability of female rats 
in the Y maze apparatus following neonatal repeated 
administration of propofol
In Fig. 5A, the total arm entries were similar among groups. 
However, there was a significantly lower percentage of spon-
taneous alternation observed in the propofol treated female 
group as compared to female control (<50% chance level and 
p<0.01) (Fig. 5B). Propofol-treated male subjects were not af-
fected in this parameter.
Unaffected social behavior of rats in the three-chamber 
social interaction test following neonatal repeated 
administration of propofol
The social behaviors of rats at P35-38 through sociability 
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test and preference for novelty in the social preference test 
were not affected by repeated propofol treatment during neo-
natal period. As shown in Fig. 6, not any significant difference 
was observed in the social behavior parameters of the three-
chamber paradigm between treated and control rats.
Impaired recognition memory of male rats in the novel 
object recognition test following neonatal repeated ad-
ministration of propofol
Fig. 7A reveals the balance of exploration of animals to the 
two identical objects during the familiarization phase to en-
sure absence of object preference that may have affected the 
following novel recognition test. During the novel recognition 
phase (Fig. 7B), all groups displayed recognition to the famil-
iar object thus significantly increased preference to the novel 
object, except the propofol treated male group. A significantly 
decreased novel object preference index (Fig. 7C) confirms 
this impairment of the propofol treated male rats in recognition 
memory (p<0.05).
Unaffected avoidance memory retention and motor 
coordination in the passive avoidance and rotarod tests 
following neonatal repeated administration of propofol
Following an aversive stimulus induced by a mild foot shock 
in the dark chamber during the conditioning phase of the one-
trial passive avoidance test, all rat groups showed retention 
to the aversive experience and avoided entering the dark 
chamber 24 h later during the test phase (data not shown). 
Repeated propofol administration in neonates did not show 
impairment in the avoidance learning and memory of rats. 
Furthermore, motor balance and coordination assessed in the 
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Fig. 9. Effects of neonatal repeated propofol administration on hippocampal proteins expression levels. Western blot analysis was conduct-
ed after behavioral experiments. Expression levels of PSD95, and NMDA & AMPA receptor subunits were measured according to female (A) 
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Fig. 8. Effects of neonatal repeated propofol administration on 
motor coordination of rats in the accelerating rotarod at P56-58 by 
measuring the latency to fall in three daily trials. Symbols indicate 
the mean ± SEM. Control (male, n=8; female, n=13) and propofol 
(male, n=10; female, n=16). No significant difference was ob-
served. 
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accelerating rotarod did not show any difference between pro-
pofol treated rats and control groups (Fig. 8).
Female-specific decreased GluN1protein expression and 
male-specific increased GluR1 protein expression of  
rat hippocampus following neonatal repeated  
administration of propofol
Using Western blot analysis, hippocampal protein expres-
sion levels were measured including PSD95, NMDA and 
AMPA receptor subunits. Propofol treated female rats (Fig. 
9A) showed a lower expression levels of GluN1 proteins than 
control females (p<0.05) while propofol treated male rats (Fig. 
9B) had a higher expression levels of GluR1 proteins than 
control males (p<0.05). Other markers were not significantly 
different among all groups in each sex.
DISCUSSION
Altered physical growth is an important sign of malnutrition. 
The current data showed an altered body weight gain of rats 
immediately after the first propofol administration, which per-
sisted until weaning period. However, during the late adoles-
cent period at P56, the decreased weight was more persistent 
in the propofol-exposed male rats. The alteration in weight 
gain during and after propofol treatment might be related to 
poor feeding behaviors following repeated administration of 
anesthesia (Hayashi et al., 2002) or the anesthetic agent itself 
could have an impact on the nutrition of animals (Anand et al., 
2004), which needs further investigations.
The generally unaffected locomotor behavior of neonatal 
propofol exposure is consistent with previous report (Karen 
et al., 2013). Motor coordination in the rotarod was not also 
affected by neonatal propofol treatment. 
Furthermore, anxiety-related and social behaviors are as 
well important behavioral alteration markers in animal models 
of various disorders. Thus far, our study is the first to assess 
the long-term outcome of neonatal repeated propofol adminis-
tration in anxiety and social behaviors in rats and we found no 
significant effect in this condition. 
Impairments in learning and memory are the mostly re-
ported consequences of neonatal propofol exposure in ani-
mal models. Inhibition of long term potentiation (LTP) in the 
hippocampus was observed (Feng et al., 2007; Gao et al., 
2014), which could be related to the decreased levels of both 
Ca2+/calmodulin-dependent protein kinase II (CaMKII) and 
phosphorylated CaMKII (pCaMKII) proteins (Gao et al., 2014). 
Thus, the long-term outcomes in learning and memory could 
be partly explained by the immediate neuroapotosis and mor-
phofunctional effects of propofol in the developing brain (Cat-
tano et al., 2008; Milanovic et al., 2010; Briner et al., 2011; Cui 
et al., 2011; Karen et al., 2013; Yu et al., 2013). On the other 
hand, increased LTP may as well affect the normal learning 
and memory formation. For example, Han et al injected na-
no-zinc oxide (nano-ZnO) intraperitoneally in Wistar rats and 
observed an over-enhanced LTP in the hippocampus but de-
creased spatial learning and memory (Han et al., 2011). Thus, 
it is suggested that a balance within the normal range of func-
tion of LTP is important and that LTP alteration in either direc-
tion will similarly affect the cognitive function.
In the present study, we found that propofol exposed rats 
have sex-specific impairments in two aspects of learning and 
memory tests that we have done. However, the mechanisms 
of this sex differences are still unclear. With the increasing in-
terest in sex differences in many health conditions, a lot of 
work needs to be done to elucidate the underlying mecha-
nisms of these disparities. Hypothetically, sex differences oc-
cur possibly due to the sex-specific onsets of neural devel-
opment processes, hormonal expressions and epigenetics 
(Brenhouse and Andersen, 2011). Thus, it would also be in-
teresting to investigate the neurobiological mechanism of the 
sex-specific outcomes of neonatal propofol exposure.
Hippocampal NMDA receptors (NMDAR) are linked to 
spatial learning and memory (Boon et al., 2005) and regula-
tion of synaptic plasticity (Nakazawa et al., 2004). Functional 
NMDARs are generally made up of a heterotetrameric as-
sembly of typically two GluN1 plus two GluN2 or mixed GluN2 
and GluN3 subunits (Paoletti et al., 2013). The present study 
showed that neonatal repeated propofol administration re-
pressed the expression of GluN1 proteins, but not GluN2 or 
GluN3, of NMDARs in the hippocampus of female rats. GluN1 
is a necessary component of functional NMDAR complexes 
(Chen et al., 2009); therefore, its decreased expression could 
affect the overall NMDAR-related learning and memory func-
tion in the hippocampal region. Indeed, disruption of GluN1 
expression in mutant mouse models of a previous study re-
vealed impairments in spatial learning and memory but not 
object recognition memory (Chen et al., 2009), which showed 
similar result to our current study. 
AMPA receptors are involved in mediating synaptic plas-
ticity; and their activation and insertion follows the NMDAR-
induced activation of CaMKII after increased calcium influx 
into the cells during LTP (Lynch, 2004; Paoletti et al., 2013). 
Increased expression or modulation of AMPA receptor sub-
units was reported to improve recognition memory (Uslaner 
et al., 2009). However, our study showed an opposite finding 
where propofol-treated male rats have an increased GluR1 
receptor subunit protein expression in the hippocampus but 
impaired recognition memory. This finding may further support 
the hypothesis that deviations of receptor expression from ei-
ther direction may show the same cognitive dysfunction. In 
another perspective, the increased GluR1 expression may be 
a compensatory outcome from the neurodegenerative con-
sequences of repeated neonatal propofol exposure in which 
GluR1 levels could have been initially reduced. However, the 
Western blot analysis adopted in this study does not discrimi-
nate the synaptic and extra-synaptic levels of GluR1, which is 
essential for the determination of synaptic activity. Neverthe-
less, the result gives us a viewpoint of the impaired recognition 
memory in propofol treated male rats. Follow up studies are 
needed in evaluating the hippocampus same period as during 
the behavior experiment to determine time-relevant changes.
The drug carrier of propofol used in this study is composed 
of soybean oil, glycerol, egg lecithin and sodium hydroxide (to 
adjust pH). Intriguingly, it was previously suggested that the 
lipid emulsion drug carrier could have an independent NMDAR 
activation properties (Weigt et al., 2002), aside from the spe-
cific action of the incorporated drugs. However, in all the lipid 
emulsions in that study, only 3 out of 9 preparations showed 
activation on NMDAR while the others did not. Furthermore, 
the experiments were conducted in vitro, making them difficult 
to compare to the in vivo situation as to whether the lipid emul-
sion could have direct access to the neurons from intraperito-
neal injection. There were two studies which used intralipid as 
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a vehicle control for the examination of the effects of prenatal 
exposure to propofol (Li et al., 2014; Xiong et al., 2014). How-
ever, both studies showed that intralipid administration did not 
affect the cleaved caspase levels and physical development 
of offspring rats. Therefore, it is less likely that the use of drug 
carrier in the current study may induce neural changes when 
given intraperitoneal to neonatal rats.
In the current study, we focused on the general expression 
of receptors in the hippocampus without dividing the subre-
gions, which are suggested to be differently related to spatial 
and recognition memories. In the previous study, it was found 
that the hippocampus is more prominent for spatial memory 
performance than recognition memory, which shares a lesser 
portion from this brain location (Broadbent et al., 2004). Thus, 
histochemical analysis of hippocampal subregions may pro-
vide additional information of the role of region-specific recep-
tor regulation in the modulation of cognitive function by repeat-
ed propofol exposure to neonates, which needs to be carefully 
examined in the future study. 
Another interesting area of investigation related to learning 
and memory is the role of acetylcholine in the toxic effects 
of profopol during the neonatal period since acetylcholine is 
important for encoding and memory acquisition (Hasselmo, 
2006). A previous study had investigated the effect of propofol 
on the hippocampal acetylcholine levels in adult rats (Kikuchi 
et al., 1998). Using in vivo microdialysis, it was shown that 
I.P. propofol injection (25 and 50  mg/kg) dose-dependently 
reduced the basal acetylcholine levels in the hippocampus by 
47% and 72 %, respectively. Whereas the experimental condi-
tions differ in the previous and current study, it could give us 
a hint of the deleterious effects of propofol on acetylcholine 
regulation. This point should be investigated in the future, es-
pecially focusing on the cholinergic system.
Translating the present findings to the clinical area would be 
challenging due to differences in the duration of brain growth 
spurt period between humans and rats (Dobbing and Sands, 
1973). It is reasonable to assume that the longer duration of 
human brain growth spurt period could have more complex 
processes than that of rodents. In clinical studies, findings re-
vealed that multiple exposures to anesthesia during the neo-
natal or toddler period in humans have higher incidences of 
learning disabilities growing up (Wilder et al., 2009; Flick et al., 
2011; Yan et al., 2014).  More clinical studies in larger popu-
lations of children or adolescents with single or multiple ex-
posures to anesthesia, such as propofol, during their infancy 
period will help in comparing with the preclinical findings. Nev-
ertheless, our ultimate goals of studying the long-term behav-
ioral and molecular effects of repeated neonatal administration 
of propofol were met including the finding of sex differences. 
From here, further elucidation of the mechanistic pathways 
will be the next step for these known behavioral outcomes. In 
conclusion, neonatal repeated propofol administration affects 
growth and neurodevelopment of rats through altered weight 
gain and sex-specific impairments in spatial (in females) and 
recognition (in males) aspects of learning and memory dur-
ing the adolescent period. The female-specific decrement of 
GluN1 NMDAR subunit and male-specific increment of GluR1 
AMPA receptor subunit protein expression in the hippocampus 
may be involved. Other aspects of behavior such as locomo-
tor activity, motor coordination and balance, anxiety, sociabil-
ity and social novelty preference, and avoidance learning and 
memory were not generally affected.
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